SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eye Laser Industry - VISX and Summit BEAM Info

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Binford, Jr. who wrote (56)9/10/1996 8:13:00 AM
From: AgAuUSA   of 178
 
John,

I agree, both cos can only go up longterm. Unfortunately, laser eye surgery is in its infancy and is having colic now. I feel Summit mgt change will make for a calmer approach to these cos. I hope Visx moves to settle their suit. I also hope Summit moves to make customers feel welcome again. It sounds like they may rethink their current business plan in light of mgt changes.

So far you are correct about Visx. I hope you watch closely the astigmatism filing. I'm certain Summit is also working on the filing. They seemed to think the first filer faces the greatest approval risk. Since I really don't know the criteria the FDA will use it is hard for me to judge the success possibilities.

With Summit having $3.00+ cash per share you would think the bottom is here. I'm just holding. May add more. Have several thousand now and liking the future outlook as it developes.

Best,

Greg
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext